Biotech · Private company · Denver, CO, US
Rock Immune, Inc.
Track this companyFree. Adds Rock Immune, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic LeukemiaFiscal year 2026 · $400KNIH RePORTER 1R41CA309908-01 · fetched Nov 12, 2026
- CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell LymphomaFiscal year 2025 · $248.3KNIH RePORTER 5R42CA261547-04 · fetched Nov 12, 2026